Dimensional Fund Advisors
BMY.RT

Dimensional Fund Advisors’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Dimensional Fund Advisors’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-14,681
Closed -$10K – 3454
2020
Q4 		$10K Hold
14,681
– – ﹤0.01% 3342
2020
Q3 		$33K Sell
14,681
-4,859
-25% -$13.9K ﹤0.01% 3317
2020
Q2 		$70K Hold
19,540
– – ﹤0.01% 3297
2020
Q1 		$74K Sell
19,540
-1,158,106
-98% -$3.82M ﹤0.01% 3297
2019
Q4 		$3.54M Buy
+1,177,646
New +$3.06M ﹤0.01% 2709

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Dimensional Fund Advisors's BMY.RT Position: Q1 2021 in Review

Dimensional Fund Advisors sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 14,681 shares — an estimated $10K sold.

Dimensional Fund Advisors first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $3.54M in Q4 2019. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Dimensional Fund Advisors reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Dimensional Fund Advisors sold 14,681 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $10K.
  • Dimensional Fund Advisors first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Dimensional Fund Advisors's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $3.54M in Q4 2019.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Dimensional Fund Advisors's 13F filing for Q1 2021, filed 14 May 2021.